A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
Clinical trial NCT03394924 · COMPLETED
Trial details
- NCT number
- NCT03394924
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-27
- Primary completion
- 2019-12-19
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.